Plummeting trust in vaccines could be lethal on its own. But there are also ways Trump’s nominee for Health and Human ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Why this news will impact the lives of people affected by Alzheimer's disease: The first disease-modifying therapies for ...

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that the first participant has been vaccinated ...

One person has died and four people have developed a potentially life-threatening kidney disease complication as part of the outbreak.

Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and ...

Health agencies, counties and state officials have been resisting efforts to provide booster jabs to Americans this fall.

Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 -- -- VAX-31 Adult Indication: ...

The FDA’s BTD process is designed to expedite the development ... followed by topline data from the booster dose by the end of 2025. Initiate Phase 2 study by the end of January 2025. Announce topline ...

But that effort is going to run into a major roadblock: the “deep state.” The phrase deep state might trigger images of ...